Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

182 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares both clinical effectiveness and cost-effectiveness of a brief, intensified therapy and diagnostic method for patients with mood and/or anxiety disorders with Treatment As Usual (TAU) at five outpatient Mental Healthcare Centers in the Netherlands.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Schema Therapy for Treatment-resistant Anxiety Disorders

NCT06298695

Anxiety Disorders

NOT_YET_RECRUITING NA

Brief Video Interventions for Depression

NCT04643964

Depressive Symptoms

COMPLETED NA

Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders

NCT01243606

Anxiety Disorders Mood Disorders

COMPLETED NA

Brief Digital CBT for Mood and Anxiety Symptoms in Acute Psychiatric Inpatients

NCT04841603

Anxiety Depressive Symptoms Distress, Emotional +4 more

COMPLETED NA

Detection and Treatment of Depression in Patients Admitted to the General Hospital

NCT00521911

Depressive Disorder Depression

UNKNOWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depressive Disorder Anxiety Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cognitive behavioral treatment/farmacotherapy intervention

Brief intervention; intake, cognitive behavioral treatment/farmacotherapy (SSRI) and ROM

Group Type EXPERIMENTAL

Cognitive behavioral treatment/farmacotherapy intervention

Intervention Type OTHER

Brief cognitive behavioral intervention/farmacotherapy; intake, treatment and ROM

Treatment As Usual

Control group, TAU

Group Type OTHER

Treatment As Usual

Intervention Type OTHER

Other: Treatment As Usual

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive behavioral treatment/farmacotherapy intervention

Brief cognitive behavioral intervention/farmacotherapy; intake, treatment and ROM

Intervention Type OTHER

Treatment As Usual

Other: Treatment As Usual

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male of female adolescents
* Adolescents aged between 18 to 65 year
* Adolescents main complaint: Mild to moderate anxiety and/or mood disorders with or without psychiatric and/or somatic co-morbidity
* Adolescents with proper understanding of the Dutch language.

Exclusion Criteria

* Adolescents with current psychotic or bipolar traits,
* Adolescents with homicidal or suicidal risk
* Adolescents with severe social disfunctioning
* No proper understanding of the Dutch language

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes